流感板块冲高，000078晋级六连板

Core Viewpoint - The flu sector experienced a significant surge, with Haiwang Bio reaching a trading limit of 4.52 yuan per share, marking its sixth consecutive increase [1] Group 1: Stock Performance - Haiwang Bio saw a rise of 9.98%, reaching a price of 4.52 yuan [2] - Renmin Tongtai increased by 8.97%, with a current price of 14.70 yuan [2] - Hainan Haiyao and Yue Wannianqing both rose over 5%, with prices of 8.52 yuan and 25.53 yuan respectively [1][2] - Jindike and Guangji Pharmaceutical also experienced gains, with increases of 3.76% and 3.58%, resulting in prices of 27.30 yuan and 9.56 yuan respectively [2]